Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer.
Zhao J, Ou B, Feng H, Wang P, Yin S, Zhu C, Wang S, Chen C, Zheng M, Zong Y, Sun J, Lu A.
Zhao J, et al. Among authors: zhu c.
Oncotarget. 2017 Apr 25;8(17):28442-28454. doi: 10.18632/oncotarget.16086.
Oncotarget. 2017.
PMID: 28415702
Free PMC article.